Home The Action Management Committee Péter Ferdinandy (HU)

Fri,19Sep2014

Prof. Péter Ferdinandy, MD, PhD, MBA

Pharmahungary Group
Hajnóczy u 6,
H-6722 Szeged, Hungary
e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
www.pharmahungary.com

Cardiovascular Research Groups,
University of Szeged, Szeged,
and Semmelweis University, Budapest,
Hungary
www.cardiovasc.com

Research Interests

  • direct effect of metabolic diseases (hyperlipidemia and diabetes) on cardioprotection
  • NO-cGMP-PKG signaling, and peroxynitrie-matrix metalloproteinase signalling
  • cardioprotection by new mechanisms: biglycan, microRNA-s
  • in vivo animal models for cardioprotection

Selected Recent Publications

  • Bencsik P, Kupai K, Giricz Z, Görbe A, Pipis J, Murlasits Z, Kocsis GF, Varga-Orvos Z, Puskas LG, Csonka C, Csont T, Ferdinandy P. Role of iNOS and peroxynitrite - matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats. Am J Physiol Heart Circ Physiol, 299: H512-518, 2010
  • Gorbe A, Giricz Z, Szunyog A, Csont T, Burley DS, Baxter GF, Ferdinandy P. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Res Cardiol. 105(5):643-50, 2010
  • Csont T, Görbe A, Bereczki E, Szunyog A, Aypar E, Tóth ME, Varga ZV, Csonka C, Fülöp F, Sántha M, Ferdinandy P. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J Mol Cell Cardiol, 48:649-52, 2010
  • Kupai K, Csonka C, Fekete V, Odendaal L, van Rooyen J, Marais de W, Csont T, Ferdinandy P. Cholesterol diet-induced hyperlipidemia impairs the cardioprotective effect of postconditioning: role of peroxynitrite. Am J Physiol Heart Circ Physiol. 297: H1729-35, 2009

 

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.